New machine learning approach improves single-cell data analysis

Our bodies are made up of around 75 billion cells. But what function does each individual cell perform and how greatly do a healthy person’s cells differ from those of someone with a disease?

How RFK Jr. might influence the FDA; Pharma’s Q3 highlights; AbbVie’s latest neuro buyout; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 3, 2024

AstraZeneca picks up Pfizer’s rare disease gene therapies, taps new R&D leader as Mene Pangalos steps down

AstraZeneca’s Alexion subsidiary is snapping up a suite of Pfizer’s preclinical gene therapies in a move to expand its toolkit in rare disease R&D. The

July 29, 2023

Parents see own health spiral as their kids’ mental illnesses worsen

After her teenage daughter attempted suicide and began to cycle through emergency rooms and mental health programs during the past three years, Sarah Delarosa noticed

August 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.